Loading...
Loading...
Among the 8 tracked institutional investors we monitor, DNLI (DENALI THERAPEUTICS INC) is held with a combined value of $777.81M across 42,340,561 shares. The largest holder is BlackRock, Inc. with a position worth $250.26M (0.00% of their portfolio). VANGUARD GROUP INC opened a new position in the most recent quarter. 3 funds increased their holdings. 3 funds reduced their position.
Total Institutional Value
$777.81M
Total Shares Held
42,340,561
Institutional Holders
8
| # | Fund | Value↓ | Portfolio % | Change |
|---|---|---|---|---|
| 1 | BlackRock, Inc. | $250.26M | 0.00% | +2.5% |
| 2 | VANGUARD GROUP INC | $215.59M | 0.00% | New |
| 3 | STATE STREET CORP | $120.42M | 0.00% | +0.1% |
| 4 | FMR LLC | $87.85M | 0.00% | -25.0% |
| 5 | BAKER BROS. ADVISORS LP | $71.65M | 0.41% | - |
| 6 | MILLENNIUM MANAGEMENT LLC | $24.44M | 0.01% | +244.3% |
| 7 | CITADEL ADVISORS LLC | $6.74M | 0.00% | -56.5% |
| 8 | Point72 Asset Management, L.P. | $867.84K | 0.00% | -97.3% |
As of the latest SEC 13F filings, BlackRock, Inc. is the largest institutional holder of DNLI with a position worth $250.26M, representing 0.00% of their portfolio. In total, 8 institutional investors hold DNLI with a combined value of $777.81M.
In the most recent quarter, 1 fund opened a new position in DNLI. Additionally, 3 increased their holdings and 3 reduced their positions.
Institutional investors hold $777.81M worth of DNLI stock across 8 positions. The largest institutional holder is BlackRock, Inc. with $250.26M in holdings.
A 13F filing is a quarterly report required by the SEC from institutional investment managers with over $100 million in assets. It discloses their holdings in U.S. equities. For DNLI, these filings reveal which major funds are accumulating or reducing positions, providing insights into institutional sentiment.
Get notified when hedge funds change their DNLI positions.